FindTrial
Sign In

Rapid combined drug sensitivity tests were conducted on carbapenem-resistant Gram-negative bacteria using flow cytometry detection technology

Rapid combined drug sensitivity tests were conducted on carbapenem-resistant Gram-negative bacteria using flow cytometry detection technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113220
Enrollment
Unknown
Registered
2025-11-26
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections caused by carbapenem-resistant bacteria

Interventions

Control group: The combined drug sensitivity test group was conducted using the meat broth micro-dilution chessboard method. 2.:NA
Experimental group: The combined drug sensitivity test group was conducted using flow cytometry detection method:NA

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.There are infected individuals caused by carbapenem-resistant Enterobacter (CRE).

Exclusion criteria

Exclusion criteria: 1.Refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
fractional inhibitory concentration index;—

Countries

China

Contacts

Public ContactFan Zhao

Peking University Shenzhen Hospital

761216457@qq.com+86 755 8392 3333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026